European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine.

Trial Profile

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 May 2014

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Bipolar disorders
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 24 Oct 2012 Status changed from active, no longer recruiting to completed as reported by UKCRN.
    • 24 Jun 2011 Lead trial investigator (Domingo Gonzalez Naranjo) added as reported by ClinicalTrials.gov.
    • 16 Apr 2011 Status changed from recruiting to active, no longer recruiting, as reported by the UKCRN record (study is in follow-up)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top